X

Vous n'êtes pas connecté

  - ZACKS.COM - All Stories - 08/Aug 14:26

PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues

Puma Biotechnology tops second-quarter earnings and revenue estimates as rising Nerlynx sales drive growth.

Articles similaires

Sorry! Image not available at this time

PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues

zacks.com - 08/Aug 14:26

Puma Biotechnology tops second-quarter earnings and revenue estimates as rising Nerlynx sales drive growth.

Sorry! Image not available at this time

Element Solutions Q2 Earnings and Revenues Beat Estimates

zacks.com - 06/Aug 14:01

ESI tops second-quarter earnings and revenue estimates on strong electronics growth amid industrial weakness.

Sorry! Image not available at this time

Element Solutions Q2 Earnings and Revenues Beat Estimates

zacks.com - 06/Aug 14:01

ESI tops second-quarter earnings and revenue estimates on strong electronics growth amid industrial weakness.

Sorry! Image not available at this time

Vistra Q2 Earnings Beat Estimates, Revenues Miss, Both Up Y/Y

zacks.com - 08/Aug 17:01

Vistra tops second-quarter earnings estimates despite sales miss, and pushes ahead with clean energy projects and share buybacks.

Sorry! Image not available at this time

Vistra Q2 Earnings Beat Estimates, Revenues Miss, Both Up Y/Y

zacks.com - 08/Aug 17:01

Vistra tops second-quarter earnings estimates despite sales miss, and pushes ahead with clean energy projects and share buybacks.

Sorry! Image not available at this time

American Axle Q2 Earnings Beat Estimates, Revenues Decline Y/Y

zacks.com - 11/Aug 16:01

AXL posts second-quarter earnings beat despite revenue dip, lifting full-year sales and cash flow guidance.

Sorry! Image not available at this time

American Axle Q2 Earnings Beat Estimates, Revenues Decline Y/Y

zacks.com - 11/Aug 16:01

AXL posts second-quarter earnings beat despite revenue dip, lifting full-year sales and cash flow guidance.

Sorry! Image not available at this time

GILD Stock Rises on Q2 Earnings and Sales Beat, '25 View Up

zacks.com - 08/Aug 13:23

GILD tops Q2 earnings, raises 2025 guidance as HIV drugs Biktarvy and Descovy drive revenue growth.

Sorry! Image not available at this time

GILD Stock Rises on Q2 Earnings and Sales Beat, '25 View Up

zacks.com - 08/Aug 13:23

GILD tops Q2 earnings, raises 2025 guidance as HIV drugs Biktarvy and Descovy drive revenue growth.

Sorry! Image not available at this time

Expeditors Q2 Earnings & Revenues Beat Estimates, Improve Y/Y

zacks.com - 05/Aug 17:10

EXPD posts second-quarter earnings and revenue beats, driven by 7% growth in both air tonnage and ocean volumes each, boosting profitability.